Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad Medical Dialogues Bureau5 Aug 2019 9:45 AM ISTLupin Ltd's Aurangabad facility is involved in the manufacture of Oral Solid Dosage, Oral Liquid and Powder for Oral Suspension products for the US...
Dr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegm Medical Dialogues Bureau10 July 2019 10:04 AM ISTThe Mucinex D brand and store brands had combined US sales of approximately USD 71 million MAT (moving annual turnover) for the most recent 12 months...
Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer Medical Dialogues Bureau10 July 2019 10:00 AM ISTLupin's Imatinib Mesylate Tablets, 100mg (base) and 400mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec...
Pfizer acquires clinical-stage Biotech Therachon for $810 million Garima12 May 2019 9:45 AM ISTNEW YORK: Pfizer recently announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately...
AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise Medical Dialogues Bureau10 May 2019 9:00 AM ISTThe treatment Trastuzumab Deruxtecan, or DS-8201, demonstrated a clinically meaningful response in patients with refractory HER2-positive metastatic...
CDSCO Committee rejects proposal for additional Indications of Dapaglofizin Meghna A Singhania5 May 2019 12:52 PM ISTNew Delhi: British-Swedish multinational drugmaker, AstraZeneca's stride to win approval from the Indian drug regulators for the additional...
Serdia Pharma launches nationwide campaign for angina awareness Medical Dialogues Bureau28 April 2019 9:25 AM ISTAs a part of this global initiative, SERDIA Pharmaceuticals has launched a comprehensive programme in India: 'Angina Awareness India'.New Delhi:...
Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India Farhat Nasim2 March 2019 11:00 AM IST"Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar...
Cipla to acquire 11.71 percent stake in Wellthy Therapeutics Garima20 Feb 2019 2:55 PM ISTNew Delhi: Drug major Cipla Monday said it has inked a pact to acquire 11.71 per cent stake in Wellthy Therapeutics. Golden cross Pharma, a...
VPS Healthcare sets aside Rs 1,000 crore for investing in Indian Hospital Space Ruby Khatun Khatun20 Oct 2017 10:35 AM ISTMUMBAI: The son-in-law of the Lulu Group founder MA Yusuf Ali and founder of VPS Healthcare Group, Dr Shamsheer Vayalil, is reported to have created a...
